Aprepitant
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68462-112 -
Package NDC
68462-112-33 -
Application number
ANDA207777 -
SPL ID
39fda225-0fa7-41d3-85b1-6ea966847331 -
SPL set ID
d72e0e10-4557-41b0-b65d-d395468cad19 -
UNII
1NF15YR6UY -
RxCUI
403810 -
RxCUI
403811 -
RxCUI
644088 -
RxCUI
754508
What the source publishes
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Active ingredients
- Aprepitant
- Form
- KIT
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Aprepitant",
"splId": "39fda225-0fa7-41d3-85b1-6ea966847331",
"labels": [
{
"setId": "d72e0e10-4557-41b0-b65d-d395468cad19",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d72e0e10-4557-41b0-b65d-d395468cad19",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d72e0e10-4557-41b0-b65d-d395468cad19"
}
],
"routes": [],
"labeler": "Glenmark Pharmaceuticals Inc., USA",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 KIT in 1 DOSE PACK (68462-112-33) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK",
"package_ndc": "68462-112-33",
"identifierStatus": "well-formed",
"marketing_start_date": "20171012"
}
],
"productId": "68462-112_39fda225-0fa7-41d3-85b1-6ea966847331",
"useDomain": "unknown",
"dosageForm": "KIT",
"productNdc": "68462-112",
"deaSchedule": null,
"genericName": "Aprepitant",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [],
"applicationNumber": "ANDA207777",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171012",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000010262",
"N0000175786",
"N0000182141",
"N0000185507",
"N0000185506"
],
"upc": [
"0368462585764",
"0368462112335",
"0368462584767",
"0368462583401"
],
"unii": [
"1NF15YR6UY"
],
"rxcui": [
"403810",
"403811",
"644088",
"754508"
],
"spl_set_id": [
"d72e0e10-4557-41b0-b65d-d395468cad19"
],
"pharm_class_epc": [
"Substance P/Neurokinin-1 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Neurokinin 1 Antagonists [MoA]",
"Cytochrome P450 3A4 Inhibitors [MoA]",
"Cytochrome P450 2C9 Inducers [MoA]",
"Cytochrome P450 3A4 Inducers [MoA]"
],
"manufacturer_name": [
"Glenmark Pharmaceuticals Inc., USA"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68462-112_39fda225-0fa7-41d3-85b1-6ea966847331"